ArticleACS catalysis2026
Recognition of a Conserved Minimal Catalaphile Explains Catalyst Generality in Enantioselective Nitroalkene Reductions.
Article in ACS catalysis, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
In catalyst development for asymmetric synthesis, generality is most often an aspirational goal rather than a reality, driven by the direct relationship between catalyst utility and product access. Strategies and tools have been developed to prospect and identify catalyst generality, but the mechanistic underpinnings for generality remain unclear. Here we investigate the selectivity-generality paradox for chiral Amidine Amide (AmA) catalyzed nitroalkene reductions, identifying the origin of generality using both experimental and computational approaches. Use of an Independent Gradient Model (IGMH) and Non-Covalent Interaction maps (NCImaps) reveal a stark contrast in recognition modes: while limited-scope catalysts rely on adaptive Van der Waals interactions that vary with substrate structure, the general AmA catalyst utilizes a conserved hydrogen-bonding network that recognizes the nitroethylene moiety-the minimal catalaphile. This understanding provides a framework for elucidating how early development focused on generality can be propagated through rational design, supported by computation, and translated to the broadest possible application. We posit that the minimal catalaphile concept, and its prioritization in development, could be a coalescing principle in hypothesis-driven development of privileged catalysts.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.